These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4607622)

  • 21. The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects.
    Weeke J; Hansen AP; Lundbaek K
    Scand J Clin Lab Invest; 1974 Apr; 33(2):101-3. PubMed ID: 4212424
    [No Abstract]   [Full Text] [Related]  

  • 22. Luteinizing releasing hormone, synthesis and arg 8 -analogs, and conformation-sequence-activity relationships.
    Chang JK; Williams RH; Humphries AJ; Johansson NG; Folkers K; Bowers CY
    Biochem Biophys Res Commun; 1972 May; 47(4):727-32. PubMed ID: 4554637
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Growth-hormone release-inhibiting hormone.
    Lancet; 1974 Jun; 1(7867):1148-50. PubMed ID: 4136663
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and biological evaluation of 4-alanine-luteinizing hormone-releasing-releasing hormone ((ALA 4 )LH-RH).
    Geiger R; Wissmann H; König W; Sandow J
    Biochem Biophys Res Commun; 1972 Dec; 49(6):1467-73. PubMed ID: 4565377
    [No Abstract]   [Full Text] [Related]  

  • 25. Pituitary and plasma growth hormone-like activity after administration of highly purified pig growth hormone-releasing factor.
    Sawano S; Arimura A; Bowers CY; Redding TW; Schally AV
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1010-4. PubMed ID: 4871941
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological activity of peptides which release growth hormone in vitro.
    Momany FA; Bowers CY; Reynolds GA; Chang D; Hong A; Newlander K
    Endocrinology; 1981 Jan; 108(1):31-9. PubMed ID: 6109621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purified ovine growth hormone releasing factor: effects on growth hormone secretion and pituitary cyclic nucleotide accumulation.
    Wilson MC; Steiner AL; Dhariwal AP; Peake GT
    Neuroendocrinology; 1974; 15(6):313-27. PubMed ID: 4373678
    [No Abstract]   [Full Text] [Related]  

  • 29. 1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs.
    Kloosterman DA; Scahill TA; Hillman RM; Cleary DL; Kubiak TM
    Pept Res; 1991; 4(2):72-8. PubMed ID: 1667740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of porcine stalk median eminence and prostaglandin E2 on rat growth hormone secretion in vivo and their inhibition by somatostatin.
    Szabo M; Frohman LA
    Endocrinology; 1975 Apr; 96(4):955-61. PubMed ID: 1091473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of growth hormone responsiveness to growth hormone releasing factor in aging rats: peripheral and central influences.
    Deslauriers N; Gaudreau P; Abribat T; Renier G; Petitclerc D; Brazeau P
    Neuroendocrinology; 1991 May; 53(5):439-46. PubMed ID: 1678494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total synthesis of hypothalamic "somatostatin".
    Sarantakis D; McKinley WA
    Biochem Biophys Res Commun; 1973 Sep; 54(1):234-8. PubMed ID: 4582377
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin.
    Brazeau P; Vale W; Burgus R; Guillemin R
    Can J Biochem; 1974 Nov; 52(11):1067-72. PubMed ID: 4609582
    [No Abstract]   [Full Text] [Related]  

  • 34. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone.
    Burgus R; Ling N; Butcher M; Guillemin R
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):684-8. PubMed ID: 4514982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.
    Lee J; Kwon A; Chae HW; Lee WJ; Kim TH; Kim HS
    Yonsei Med J; 2018 Dec; 59(10):1174-1180. PubMed ID: 30450851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of somatostatin from pigeon pancreas.
    Spiess J; Rivier JE; Rodkey JA; Bennett CD; Vale W
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2974-8. PubMed ID: 288081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Super-active analogs of growth hormone-releasing factor (1-29)-amide.
    Lance VA; Murphy WA; Sueiras-Diaz J; Coy DH
    Biochem Biophys Res Commun; 1984 Feb; 119(1):265-72. PubMed ID: 6231028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
    Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE
    Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo growth hormone responsiveness to growth hormone-releasing factor in male and female Zucker rats.
    Renier G; Gaudreau P; Deslauriers N; Brazeau P
    Neuroendocrinology; 1989 Oct; 50(4):454-9. PubMed ID: 2510049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.